These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21323509)

  • 21. Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis.
    Shimauchi T; Hirakawa S; Suzuki T; Yasuma A; Majima Y; Tatsuno K; Yagi H; Ito T; Tokura Y
    J Dermatol; 2013 Oct; 40(10):805-12. PubMed ID: 23915382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo effects of non-steroidal antiinflammatory drugs on oxidative stress-related parameters of human erythrocytes.
    Orhan H; Inanici F; Arslan S; Hasçelik Z; Sahin G
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):403-8. PubMed ID: 10445405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of effects of selenomethionine-enriched yeast supplementation on various immunological and chemical parameters of skin and blood in psoriatic patients.
    Harvima RJ; Jägerroos H; Kajander EO; Harvima IT; Aalto ML; Neittaanmäki H; Naukkarinen A; Kantola M; Miettinen UK; Horsmanheimo M
    Acta Derm Venereol; 1993 Apr; 73(2):88-91. PubMed ID: 8103273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis.
    Toth DP; Papp K; Gratton D
    Dermatol Ther; 2008; 21 Suppl 3():S6-14. PubMed ID: 19076630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.
    Demirdag K; Yilmaz S; Ozdarendeli A; Ozden M; Kalkan A; Kilic SS
    Hepatogastroenterology; 2003; 50(51):766-70. PubMed ID: 12828081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
    Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
    Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efalizumab: a biological agent for the treatment of psoriasis.
    Hodulik S; Hadi S
    Rev Recent Clin Trials; 2006 May; 1(2):165-8. PubMed ID: 18473968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.
    Cather JC; Cather JC; Menter A
    Expert Opin Biol Ther; 2003 Apr; 3(2):361-70. PubMed ID: 12662148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic therapy for psoriasis: the T-cell-targeted therapies efalizumab and alefacept.
    Weinberg JM; Tutrone WD
    Cutis; 2003 Jan; 71(1):41-5. PubMed ID: 12553629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efalizumab in the treatment of psoriasis: when comorbidity is an issue.
    Prignano F; Buggiani G; Lotti T
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S25-9. PubMed ID: 18837730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients.
    Kharaeva Z; Gostova E; De Luca C; Raskovic D; Korkina L
    Nutrition; 2009 Mar; 25(3):295-302. PubMed ID: 19041224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-associated alteration of blood thiol-group-related antioxidants in smokers.
    Liu CS; Wei YH
    Environ Res; 1999 Jan; 80(1):18-24. PubMed ID: 9931223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis.
    Joshi A; Bauer R; Kuebler P; White M; Leddy C; Compton P; Garovoy M; Kwon P; Walicke P; Dedrick R
    J Clin Pharmacol; 2006 Jan; 46(1):10-20. PubMed ID: 16397279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood lipid peroxidation, antioxidant enzyme activities and hemorheological changes in autistic children.
    László A; Novák Z; Szőllősi-Varga I; Hai du Q; Vetró Á; Kovács A
    Ideggyogy Sz; 2013 Jan; 66(1-2):23-8. PubMed ID: 23607226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efalizumab: Advancing psoriasis management with a novel, targeted T-cell modulator.
    Papp KA
    Drugs Today (Barc); 2004 Nov; 40(11):889-99. PubMed ID: 15645002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
    Papp KA; Miller B; Gordon KB; Caro I; Kwon P; Compton PG; Leonardi CL;
    J Am Acad Dermatol; 2006 Apr; 54(4 Suppl 1):S164-70. PubMed ID: 16488338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse, rebound, and psoriasis adverse events: an advisory group report.
    Carey W; Glazer S; Gottlieb AB; Lebwohl M; Leonardi C; Menter A; Papp K; Rundle AC; Toth D
    J Am Acad Dermatol; 2006 Apr; 54(4 Suppl 1):S171-81. PubMed ID: 16488339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effectiveness and safety experience with efalizumab in the treatment of patients with moderate-to-severe plaque psoriasis in Taiwan: results of an open-label, single-arm pilot study.
    Tsai TF; Liu MT; Liao YH; Licu D
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):345-52. PubMed ID: 18005021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione peroxidase, reduced glutathione, superoxide dismutase and catalase in red cells of patients with hairy cell leukemia.
    Arruda VR; Salles TS; Costa FF; Saad ST
    Neoplasma; 1996; 43(2):99-102. PubMed ID: 8843970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.